Connect with us

Cannabis News

Auto Union Workers Go On Strike and Get 25% Off at Their Local Marijuana Dispensary in Michigan

Published

on


auw workers strike

Ultra Cannabis, a recreational dispensary headquartered in Michigan, is demonstrating its solidarity with the committed members and suppliers of the United Auto Workers (UAW) union during the ongoing strike against prominent automakers. In a gesture of support, Ultra Cannabis has unveiled an exclusive 25% discount for all UAW members and supplier associates who provide a valid union ID.

 

The UAW strike, which commenced on September 15, 2023, has garnered widespread national interest, particularly among Ford Motor Co. employees. General Motors and Stellantis have joined forces to advocate for fair contracts and improved working conditions. As the strike’s effects ripple through Michigan, impacting both families and communities, Ultra Cannabis is steadfast in its dedication to providing vital support to UAW members and their suppliers during these challenging times.

 

Jonathan Yaldo, the owner of Ultra Cannabis, expressed that UAW members and suppliers are more than just customers; they are our neighbors, friends, and extended family. They are committed to alleviating the financial burdens of the strike, and this discount is a small but meaningful gesture to illustrate the strength that comes from unity in assisting one another.

 

The 18207 West 8 Mile in Detroit dispensary is extending a 25% discount on all recreational cannabis items to UAW members and supplier associates who can present a valid ID. This offer remains accessible for the entire UAW and supplier strike duration.

Strike Expands To 20 States

The United Auto Workers union escalated its strike against major automakers, with workers at all 38 parts-distribution centers operated by General Motors and Stellantis, the parent company of Jeep and Ram, in 20 states walking out. However, Ford was spared from further shutdowns.

 

Ford managed to avoid additional strikes because the company had addressed some of the union’s demands during negotiations over the past week, as UAW President Shawn Fain reported during an online presentation to union members.

 

Fain noted, “Substantial progress has been achieved at Ford. While significant issues still require resolution, it’s important to acknowledge Ford’s genuine commitment to reaching a mutually agreeable deal. However, the situation at GM and Stellantis presents a contrasting scenario.

 

He emphasized that GM and Stellantis, the successor to Fiat Chrysler, have rebuffed the union’s propositions concerning cost-of-living adjustments, profit sharing, and job security, stating that they will require significant pressure to agree.

 

GM stated that it had proposed five “historic” offers encompassing wage and job security considerations. GM characterized the UAW’s leadership’s decision to escalate the strike as unnecessary, alleging that personal agendas drove it.

 

Stellantis, on the other hand, asserted that it had presented “a highly competitive proposal.” They claim to offer all current full-time hourly employees with earnings between $80,000 and $96,000 within four years and seven months, focusing on “workforce stability” during that period. The company reported that the UAW had yet to respond.

 

Instead of targeting additional production plants on Friday, the UAW directed its actions toward the distribution centers responsible for supplying parts to car dealer service departments. This strategic move could involve consumers in the dispute if dealers experience shortages of essential elements.

 

According to the UAW, more walkouts are expected to impact 5,600 more workers and the nearly 13,000 who initiated strikes last week at three Ford, GM, and Stellantis assembly plants. The initial strikes will persist, as confirmed by the union.

 

It’s worth noting that the UAW continues to refrain from targeting plants responsible for producing Detroit’s best-selling vehicles, such as the Ford F-150 and Stellantis’ Ram pickups. These models account for a significant portion of the companies’ revenue and profits. This approach reflects the union’s strategy of gradually intensifying the strike’s impact on the automakers.

Impact of the Strike

Deutsche Bank analysts have estimated that General Motors (GM), Ford, and Stellantis have collectively lost production of more than 16,000 vehicles since the strike commenced. This strike began at a Ford assembly plant near Detroit, a GM factory in Wentzville, Missouri, and a Stellantis Jeep plant in Toledo, Ohio.

 

Alongside this, Anderson Economic Group, a consulting firm in Michigan specializing in industry analysis, has calculated that the strike has inflicted approximately $1.6 billion in economic damage. This damage includes over $500 million for the automotive companies and more than $100 million in lost wages for striking workers and those laid off.

 

So far, the strike has led to the temporary layoff of approximately 6,000 workers by the automakers and some of their suppliers. General Motors even had to close down a factory in Kansas that depended on parts produced at the Wentzville plant.

 

However, the strike’s impact on nationwide car dealerships has not been evident. Analysts suggest it will take a few weeks before a significant shortage of new vehicles becomes apparent, though prices may increase sooner if a prolonged strike prompts panic buying.

Amid negotiations, the union is pushing for wage increases of around 36% over four years, citing the carmakers’ substantial recent profits and high CEO compensation as justification.

 

The companies, in response, have offered a little over half of that amount, citing their need to invest in transitioning from gas-powered vehicles to electric ones. Some of the union’s demands, such as 40 hours’ pay for a 32-hour work week, have been outright dismissed.

 

While Ford has made some concessions, including reinstating cost-of-living wage increases and improved profit-sharing and job security, significant gaps still exist in critical economic issues.

 

The union has been negotiating concurrently with all three Detroit giants instead of focusing on one company and setting a pattern for contracts at the others. By favoring Ford after a week of negotiations, the UAW is following its traditional bargaining pattern of securing the best deal from one company and expecting the others to match it.

 

The recent escalation of the strike, targeting parts distribution centers, could quickly impact GM and Stellantis. According to analysts, this strategic move is seen as a bold and potentially risky poker move by the UAW. However, some experts believe involving current owners of GM and Stellantis vehicles in the dispute may backfire on the union as those needing car repairs may not be sympathetic to the strike.

 

Despite the strike expansion, it involves only a fraction of the UAW’s total membership, allowing the union’s strike fund to last longer as most members continue to work under the expired contract and contribute to the fund. However, an extended strike raises the risk of division among workers receiving entire paychecks and those receiving strike benefits.

 

Conclusion

The ongoing strike in the automotive industry is causing substantial economic damage, with both carmakers and workers feeling its effects. The negotiations remain contentious, with significant gaps between the union’s demands and the companies’ offers.

 

The strike’s impact on the availability and prices of new vehicles is expected to become more pronounced in the coming weeks. The dynamic situation will evolve as negotiations progress and the strike’s effects ripple through the industry.

 

CANNABIS INDUSTRY AND UNIONS, READ ON…

CANNABIS NDUSTRY UNIONS

CANNABIS INDUSTRY WORKERS JOINS UNION, GETS FIRED, WINS JOB BACK!



Source link

Cannabis News

Is There Any Green Left in the Green Rush?

Published

on

By


cannabis jobs that pay well

The cannabis industry has undergone a remarkable transformation over the past decade, evolving from a largely underground market to a legitimate and booming sector. As more states and countries legalize cannabis for medical and recreational use, the demand for skilled professionals has surged. This growth has led to the emergence of various high-paying cannabis job opportunities that cater to a wide range of expertise. In this article, we will explore some of the highest-paying jobs in the cannabis industry, their roles, responsibilities, and the skills required to excel in these positions.

 

 The Cannabis Industry Landscape

 

Before diving into specific job roles, it’s essential to understand the current landscape of the cannabis industry. As of 2023, the global cannabis market is projected to reach over $70 billion by 2028, driven by increasing legalization, changing consumer attitudes, and growing acceptance of cannabis for both medicinal and recreational purposes. This rapid growth has created a demand and jobs for professionals across various sectors, including cultivation, retail, manufacturing, marketing, and compliance.

 

Factors Driving Job Growth

 

1. Legalization: As more regions legalize cannabis, new businesses are emerging, creating job opportunities across the supply chain.

2. Consumer Demand: The growing acceptance of cannabis products has led to increased consumer demand for quality products and services.

3. Innovation: The industry is witnessing continuous innovation in product development and technology, necessitating skilled professionals to drive these advancements.

4. Regulatory Compliance: Navigating complex regulations requires experts who can ensure compliance with local and federal laws.

 

With this backdrop in mind, let’s delve into some of the highest-paying jobs within the cannabis industry.

 

 1. Chief Financial Officer (CFO)

 

The Chief Financial Officer (CFO) plays a critical role in any organization, and this is especially true in the cannabis industry. As companies navigate a complex financial landscape marked by fluctuating regulations and banking challenges, a skilled CFO is essential for guiding financial strategy.

Responsibilities

  • Financial Planning: Developing long-term financial strategies that align with company goals.

  • Budget Management: Overseeing budgets and ensuring efficient allocation of resources.

  • Regulatory Compliance: Ensuring adherence to financial regulations specific to the cannabis industry.

  • Investor Relations: Managing relationships with investors and stakeholders.

 

Salary Range

 

CFOs in the cannabis industry can expect to earn between $125,000 and $250,000 annually, depending on the size of the company and its location.

 

 Skills Required

 

  • Strong analytical skills

  • Experience in financial management

  • Knowledge of cannabis regulations

  • Excellent communication skills

 

2. Chief Operations Officer (COO)

The Chief Operations Officer (COO) is responsible for overseeing daily operations within a cannabis company. This role is crucial for ensuring that all aspects of the business run smoothly and efficiently.

 

Responsibilities

  • Operational Strategy: Developing strategies to improve operational efficiency.

  • Team Management: Leading various departments such as cultivation, production, and sales.

  • Process Optimization: Implementing best practices for production and distribution.

  • Quality Control: Ensuring that products meet regulatory standards and quality expectations.

 

Salary Range

 

COOs typically earn between $125,000 and $200,000 annually.

 

Skills Required

 

  • Strong leadership abilities

  • Experience in operations management

  • Knowledge of supply chain logistics

  • Problem-solving skills

 

3. Vice President of Cultivation

 

The Vice President of Cultivation oversees all aspects of growing cannabis plants from seed to harvest. This role requires extensive knowledge of horticulture as well as business acumen.

 

Responsibilities

 

  • Cultivation Management: Directing cultivation operations to maximize yield and quality.

  • Research & Development: Staying updated on new cultivation techniques and technologies.

  • Staff Training: Training staff on best practices for plant care.

  • Compliance Oversight: Ensuring that cultivation practices adhere to state regulations.

 

Salary Range

This position typically commands a salary between $140,000 and $185,000 annually.

 

Skills Required

 

 

4. Cannabis Consultant

Cannabis consultants provide expert advice on various aspects of running a cannabis business. They often work with startups or established companies looking to optimize their operations or navigate regulatory challenges.

Responsibilities

 

  • Regulatory Guidance: Helping businesses understand local and federal regulations.

  • Business Strategy: Advising on market entry strategies or operational improvements.

  • Training Programs: Developing training programs for staff on compliance issues.

  • Market Analysis: Conducting research on market trends and consumer preferences.

 

Salary Range

 

Cannabis consultants can earn anywhere from $100,000 to over $250,000, depending on their expertise and client base.

 

Skills Required

 

5. Dispensary Manager

Dispensary managers oversee the daily operations of retail locations selling cannabis products. This role combines customer service with business management skills.

 

Responsibilities

 

  • Staff Management: Hiring, training, and supervising dispensary staff.

  • Inventory Control: Managing inventory levels to ensure product availability.

  • Customer Service: Ensuring high levels of customer satisfaction through excellent service.

  • Sales Strategy: Developing sales strategies to increase revenue.

 

 Salary Range

 

Dispensary managers typically earn between $60,000 and $120,000, depending on location and experience.

 

Skills Required

  • Strong leadership qualities

  • Experience in retail management

  • Knowledge of cannabis products

  • Excellent interpersonal skills

 

6. Extraction Technician

Extraction technicians play a vital role in producing concentrated cannabis products such as oils and edibles. This position requires technical expertise in extraction methods.

 

Responsibilities

 

  • Extraction Processes: Performing extraction using various techniques (e.g., CO2 extraction).

  • Equipment Maintenance: Maintaining extraction equipment to ensure safety and efficiency.

  • Quality Assurance: Testing products for potency and purity.

  • Documentation: Keeping detailed records of extraction processes for compliance purposes.

Salary Range

 

Extraction technicians can earn between $50,000 and $90,000, depending on their level of experience.

 

Skills Required

  • Technical knowledge of extraction methods

  • Attention to detai Ability to work with laboratory equipment

  • Strong problem-solving skills

 

7. Marketing Manager

Marketing managers in the cannabis industry are responsible for developing marketing strategies that promote products while adhering to strict advertising regulations unique to this sector.

 

Responsibilities

 

  • Brand Development: Creating a strong brand identity that resonates with consumers.

  • Campaign Management: Planning and executing marketing campaigns across various channels.

  • Market Research: Analyzing market trends to identify opportunities for growth.

  • Social Media Management: Engaging with customers through social media platforms while complying with advertising regulations.

 

Salary Range

 

Marketing managers can expect salaries ranging from $70,000 to $150,000, depending on experience and company size.

 

Skills Required

 

  • Strong understanding of digital marketing

  • Creativity

  • Excellent communication skills

  • Ability to analyze market data

 

8. Compliance Officer

Compliance officers ensure that cannabis businesses adhere to all local, state, and federal regulations governing their operations. This role is crucial for avoiding legal issues that could jeopardize a business’s future.

 

 

Responsibilities

 

  • Regulatory Monitoring: Keeping up-to-date with changes in laws affecting the cannabis industry.

  • Policy Development: Creating internal policies that align with legal requirements.

  • Training Staff: Educating employees about compliance issues related to their roles.

  • Auditing Practices: Conducting regular audits to ensure adherence to regulations.

 

Salary Range

 

Compliance officers typically earn between $70,000 and $120,000, depending on experience level.

 

Skills Required

 

 

9. Product Development Scientist

Product development scientists are responsible for creating new cannabis products or improving existing ones. Their work involves research into formulations that meet consumer needs while adhering to safety standards.

 

 Responsibilities

 

  • Researching new product formulations

  • Conducting stability testing

  • Collaborating with marketing teams

  • Ensuring compliance with health regulations

 

Salary Range

 

Product development scientists can earn between $80,000 and $130,000, depending on their expertise level.

 

Skills Required

 

  • Strong background in chemistry or biology

  • Creativity

  • Problem-solving abilities

  • Knowledge of regulatory standards

 

Check for open jobs in the cannabis industry near you on our job board by clicking here!

 

 Conclusion

 

The cannabis industry presents an array of high-paying job opportunities across various sectors—from finance and operations management to marketing and compliance. As legalization continues to spread globally, skilled professionals will be essential for navigating this rapidly evolving landscape. Whether you’re an experienced professional looking for a career change or someone entering the job market for the first time, there are numerous pathways available within this exciting field. By acquiring relevant skills and knowledge about the industry’s unique challenges and opportunities, you can position yourself for success in one of today’s most dynamic job markets.

 

HIGHEST PAYING JOBS IN WEED, READ ON…

BEST PAYING MARIJUANA JOBS

HIGHEST PAYING WEED JOBS, CHECK THE LASTEST HERE!



Source link

Continue Reading

Cannabis News

Not Just Alcohol Sales Dropping, Anxiety Medication Prescriptions Plummet in States with Legal Cannabis Programs

Published

on

By


anxiety medications drop with cannabis

The legalization of marijuana has sparked a significant shift in the landscape of mental health treatment, particularly concerning anxiety disorders. Recent studies have indicated a notable decrease in prescriptions for anti-anxiety medications, especially benzodiazepines, in states where marijuana has been legalized. This phenomenon raises important questions about the implications for pharmaceutical companies that have long dominated the market for anxiety treatments. In this article, we will explore the connection between legal marijuana and the decline in anxiety medication prescriptions, delve into the broader implications for the pharmaceutical industry, and consider what this means for patients and healthcare providers.

 

Understanding Anxiety Disorders and Current Treatment Options

 

The Prevalence of Anxiety Disorders

 

Anxiety disorders are among the most common mental health issues affecting millions of individuals worldwide. According to the World Health Organization (WHO), anxiety disorders affect approximately 264 million people globally. These disorders encompass a range of conditions, including generalized anxiety disorder (GAD), social anxiety disorder, panic disorder, and specific phobias. Symptoms can vary widely but often include excessive worry, restlessness, fatigue, difficulty concentrating, and physical symptoms such as increased heart rate and sweating.

 

Traditional Treatments for Anxiety

 

Historically, treatment options for anxiety disorders have included psychotherapy and pharmacotherapy. Common pharmacological treatments include:

 

  • Benzodiazepines: Medications such as diazepam (Valium), lorazepam (Ativan), and alprazolam (Xanax) are frequently prescribed for short-term relief of acute anxiety symptoms. While effective, these medications carry risks of dependency and withdrawal symptoms.

  • Selective Serotonin Reuptake Inhibitors (SSRIs): Drugs like sertraline (Zoloft) and fluoxetine (Prozac) are often used as first-line treatments for chronic anxiety disorders. They work by increasing serotonin levels in the brain but can take several weeks to show effects.

  • Cognitive Behavioral Therapy (CBT): This form of psychotherapy is widely regarded as an effective treatment for anxiety disorders. CBT focuses on changing negative thought patterns and behaviors associated with anxiety.

 

Despite their effectiveness, many patients experience side effects from these medications or find them insufficient in managing their symptoms. As a result, there is growing interest in alternative treatments, including legal marijuana.

 

 The Rise of Legal Marijuana

In recent years, various states in the U.S. have moved toward legalizing marijuana for both medical and recreational use. As of 2023, over 30 states have legalized medical marijuana, while several others have legalized it for recreational use. This trend reflects changing public attitudes toward cannabis and increasing recognition of its potential therapeutic benefits.

 

 Medical Marijuana and Anxiety Relief

 

Cannabis contains numerous compounds known as cannabinoids, with tetrahydrocannabinol (THC) and cannabidiol (CBD) being the most studied. THC is responsible for the psychoactive effects associated with marijuana use, while CBD is non-psychoactive and has garnered attention for its potential therapeutic properties.

 

Research suggests that CBD may help alleviate anxiety symptoms without the side effects commonly associated with traditional anti-anxiety medications. A 2019 study published in The Permanente Journal found that CBD significantly reduced anxiety scores in a group of patients within a month of treatment.

 

The Connection Between Legal Marijuana and Reduced Anxiety Medication Prescriptions

 

A groundbreaking study published in JAMA Network Open examined prescription data from states that legalized marijuana. The researchers found that states with medical cannabis laws experienced a 12.4% reduction in benzodiazepine prescriptions, while those with recreational laws saw a 15.2% decrease. This data suggests that patients may be substituting cannabis for traditional anti-anxiety medications.

 

 Patient Behavior and Preferences

 

Several factors may contribute to patients’ decisions to turn to legal marijuana instead of pharmaceuticals:

 

1. Perceived Safety: Many individuals view cannabis as a safer alternative to benzodiazepines due to the latter’s association with dependency and withdrawal issues.

 

2. Efficacy: Patients often report positive experiences with cannabis in managing their anxiety symptoms, leading them to prefer it over conventional medications.

 

3. Holistic Approach: Cannabis is often perceived as part of a more holistic approach to health that includes lifestyle changes, mindfulness practices, and alternative therapies.

 

4. Accessibility: In states where cannabis is legal, obtaining it may be easier than navigating the healthcare system to secure prescriptions for traditional medications.

 

 Implications for Pharmaceutical Companies

 

The decline in benzodiazepine prescriptions linked to legal marijuana poses significant challenges for pharmaceutical companies that produce these medications. Here are some key implications:

 

Market Dynamics

 

As more patients seek cannabis as an alternative treatment for anxiety, pharmaceutical companies may face reduced demand for their products. This shift could lead to decreased revenue from anti-anxiety medications, prompting companies to reevaluate their market strategies.

 

Research and Development Focus

 

Pharmaceutical companies may need to adapt by investing in research related to cannabis-based therapies or developing new products that incorporate cannabinoids. Some companies are already exploring synthetic cannabinoids or formulations that combine traditional pharmaceuticals with cannabis extracts.

 

Regulatory Challenges

 

The evolving legal landscape surrounding cannabis presents regulatory challenges for pharmaceutical companies. As more states legalize marijuana, there may be increased scrutiny regarding its safety and efficacy compared to traditional medications.

 

Broader Implications for Mental Health Treatment

The rise of legal marijuana as a treatment option signals a potential shift in how mental health care is approached:

 

1. Integration of Cannabis into Treatment Plans: Healthcare providers may begin incorporating cannabis into treatment plans alongside traditional therapies. This integration could lead to more individualized care tailored to patients’ preferences.

 

2. Increased Focus on Patient-Centered Care:The growing acceptance of cannabis reflects a broader trend toward patient-centered care models that prioritize patient preferences and experiences in treatment decisions.

 

3. Need for Education: As patients increasingly seek information about cannabis as a treatment option, healthcare providers must be equipped with knowledge about its benefits and risks to guide informed decision-making.

 

Potential Risks and Considerations

 

While legal marijuana offers promising alternatives for managing anxiety, it is essential to consider potential risks:

 

1. Lack of Regulation:The cannabis industry is less regulated than pharmaceuticals, leading to concerns about product quality, dosing accuracy, and potential contaminants.

 

2. Individual Variability: Responses to cannabis can vary widely among individuals due to factors such as genetics, tolerance levels, and underlying health conditions.

 

3. Potential for Misuse: While many individuals use cannabis responsibly, there is potential for misuse or over-reliance on it as a coping mechanism.

 

 Conclusion

 

The link between legal marijuana and decreased prescriptions for anti-anxiety medications marks a significant development in mental health treatment paradigms. As more patients turn to cannabis as an alternative therapy, pharmaceutical companies must adapt to this changing landscape by reevaluating their strategies and investing in research related to cannabinoid-based treatments. For patients grappling with anxiety disorders, this shift could herald a new era of treatment options that prioritize safety, efficacy, and individual preferences. However, it also necessitates ongoing dialogue among healthcare providers about the best approaches to integrate cannabis into mental health care while ensuring patient safety.As we move forward into this evolving landscape of mental health treatment options, it is crucial to remain vigilant about the implications of these changes—both positive and negative—for patients seeking relief from anxiety disorders and the broader healthcare system at large.

 

 

This article provides an extensive overview of how the legalization of marijuana is linked to changes in medication prescriptions for anxiety disorders while discussing its implications on pharmaceutical companies and mental health treatment paradigms overall.

 

CANNABIS REPLACES BENZOS? READ ON…

CANNABIS FOR BENZOS

CANNABIS FOR BENZODIAZEPINES – DO THEY REPLACE THEM?



Source link

Continue Reading

Cannabis News

An Important Lesson from the 2024 Elections

Published

on

By


lesson learned in 2024 elections

Retrospect: An Important Lesson to learn from the 2024 Elections

Well folks, here we are again. Donald Trump is back in the White House, and if his previous term taught us anything, we’re strapping in for one hell of a rollercoaster ride. I can already feel my inbox filling up with requests to write about the latest Trump cannabis controversy or whatever inflammatory tweet is setting the internet ablaze.

But I’ll be honest with you – I’m going to try my damnedest to avoid turning this platform into yet another Trump commentary channel. Lord knows we’ve got enough of those already. Between the mainstream media’s obsession with every presidential syllable and the circus surrounding Elon Musk and RFK Jr.’s alliance with Trump, we’re already drowning in political theater. I mean, just look at the current media frenzy over “Did Elon Nazi Salute?” after Trump’s inauguration speech. If that’s any indication, we’re in for four years of non-stop sensationalism.

Here’s the thing though – as someone who prides himself on staying above the partisan fray (and believe me, that’s getting harder by the day), I feel obligated to share some hard-earned wisdom about navigating the cannabis landscape during these politically charged times. The last four years under Biden’s administration taught us some valuable lessons about political promises and cannabis reform, and those insights are more relevant than ever as we enter this new chapter.

So grab your favorite strain, settle into your comfy spot, and let old Reginald share some perspective on what we’ve learned and how to keep our heads straight during what’s sure to be an… interesting four years ahead.

If there’s one thing I’ve learned from years of covering cannabis politics, it’s that weed polls better than politicians – and boy, do they know it. It might sound like I’m hitting the bong too hard, but the numbers don’t lie. Election after election, cannabis legalization consistently polls higher than any candidate running for office. With pseudo-legalization spreading across the country like wildfire, there are more cannabis supporters than ever before, making us quite the tempting voting bloc.

This reality wasn’t lost on the Democrats during their four-year stint. They dangled cannabis reform like a carrot on a stick, making grand promises about prioritizing legalization. Remember Kamala Harris, suddenly becoming cannabis’s biggest cheerleader? The same Kamala who oversaw countless marijuana prosecutions as California’s Attorney General was now preaching about social justice and legalization. The irony was thicker than smoke in a hotboxed Volkswagen.

For the first few years of the Biden administration, we got nothing but lip service. Then, as election season approached – wouldn’t you know it – suddenly cannabis reform became urgent. Pot pardons! Rescheduling! It was like watching a dealer who ghosted you for months suddenly sliding into your DMs with “you up?”

And some folks ate it up. I saw countless posts from well-meaning stoners declaring their undying loyalty to Biden-Harris based solely on these eleventh-hour cannabis promises. But let’s get real – those pardons didn’t free a single soul from prison, and the rescheduling circus? Well, that’s still stuck in bureaucratic limbo, likely to face years of litigation if it ever materializes.

Here’s the kicker though – despite all this pot pandering, Trump still won. Why? Because while cannabis reform is important, Americans were more concerned about putting food on their tables, feeling safe in their communities, and managing the immigration crisis. The Democrats were so busy virtue signaling about helping marginalized communities that they forgot about the broader population’s immediate concerns. That’s like focusing on growing exotic strains while your basic crops are dying – it might sound cool, but it won’t feed the masses.

The result? Not only did they lose the election, but they strung along millions of cannabis supporters for absolutely nothing. No legalization, no meaningful reform, just empty promises and disappointed voters. And therein lies our lesson, my friends. Politicians will always love pot pandering because they know we’re passionate about legalization. But when their promises go up in smoke, we’re the ones left holding an empty bag.

Here’s a draft in Reginald Reefer’s voice:

Let me tell you why I stay away from political parties like they’re contaminated bathwater. It’s not because I don’t care about society or our collective rights – quite the opposite. It’s because these parties are like ill-fitting suits; they might look good on the rack, but once you try them on, nothing quite sits right.

Take me, for example. On some issues, I’m as “Republican” as they come. I believe in keeping government small (because let’s face it, they tend to mess up everything they touch), rewarding merit over handouts, cutting through red tape, and protecting individual liberties. You know, the whole “leave me alone to grow my plants in peace” mentality.

But flip the coin, and suddenly I’m singing from the Democratic hymnal. I believe in drug reform (obviously), holding big corporations accountable for their shenanigans, protecting Mother Earth, and letting people love whoever they damn well please. Some might say this makes me a libertarian, but I prefer to think of myself as an anarchist – not in the “chaos in the streets” sense, but in the “I don’t need a master telling me what to do” sense.

Now, if I were to play the political game (which I’m not, but let’s pretend), here’s how I’d approach it. During campaign season? Sure, I’d fight like hell to get my candidate in office. Wave the signs, spread the word, do the whole song and dance. But the moment they win? That’s when the real work begins.

See, this is where most people get it wrong. They treat their political party like a sports team, blindly cheering even when their players are dropping the ball. But that’s not how democracy should work. The minute your candidate takes office, you need to transform from their biggest cheerleader into their harshest critic.

Stop swooning over their tweets and start scrutinizing their actions. Forget what they promised on the campaign trail – what are they actually doing now? Are they following through, or are they just blowing smoke? If they’re not living up to their word, it’s time to make some noise. Call your representatives, flood their offices with emails, make your voice heard.

That’s the thing about political promises – they’re like rolling papers in the wind unless someone holds these politicians accountable. And who better to do that than the people who put them in office? Don’t let them get comfortable. Don’t let them forget who they work for.

So over these next four years, whether you’re a Trump supporter or just someone trying to navigate this political circus, remember: Your job isn’t to defend your candidate’s every move. Your job is to keep them honest, keep them working, and keep them afraid of disappointing their constituents. Because at the end of the day, politicians are like cannabis plants – they need constant attention and occasional pruning to produce anything worthwhile.

Let’s talk about the orange elephant in the room. Love him or hate him, Trump isn’t your typical politician – mainly because he isn’t one. He’s more like a chaos wizard who somehow got hold of the nuclear codes. But here’s the thing that makes covering Trump so interesting: unlike most politicians who make promises they never intend to keep, this guy actually follows through on some wild stuff.

Take his first few weeks back in office. While the media was having a meltdown about his latest tweet, Trump was busy declassifying JFK and MLK documents that have been gathering dust for decades. But the real head-turner? Pardoning Ross Ulbricht, aka the Dread Pirate Roberts. Here’s a guy who got two life sentences without parole for… what exactly? Creating a website? Sure, people sold drugs on the Silk Road, but by that logic, we should throw Mark Zuckerberg in prison every time someone sells weed through Facebook Messenger.

And he’s not done. RFK Jr. – the black sheep of the Kennedy family who’s been raising hell about pharmaceutical companies – is set to head Health and Human Services. Meanwhile, Trump’s already making good on his immigration promises faster than you can say “build the wall.” It’s clear this isn’t the same Trump from 2016. He’s got new allies, new strategies, and seemingly fewer fucks to give than ever before.

But here’s where things get murky, folks. While Trump’s making moves that have libertarians and anti-establishment types cheering, he’s also cozying up to some seriously sketchy characters. Take Larry Ellison, the Oracle overlord who’s got deeper CIA connections than my grow room has spider mites. For those who don’t know, Oracle started as a CIA project in 1977 with Ellison at the helm, though they’ll swear up and down it’s all ancient history. Yeah, and I’m just growing tomatoes in my basement.

What’s particularly concerning is all this talk about using AI to develop mRNA vaccines. I don’t know about you, but combining artificial intelligence, experimental vaccines, and a company with intelligence agency roots sounds like the plot of a dystopian novel I don’t want to live through.

So here we are, watching Trump do some genuinely positive things while simultaneously setting up what could be the infrastructure for a technocratic surveillance state. It’s like finding out your dealer is giving you great prices but also installing cameras in your house. Sure, the weed’s good, but at what cost?

This is why, my friends, we need to stay vigilant. Celebrate the wins when they come, but keep your eyes wide open and your bullshit detectors finely tuned. Because in Trump’s America 2.0, the only thing we can be certain of is uncertainty itself.

 

TRUMP ON MARIJUANA LEGALIZATION, READ ON…

TRUMP MARIJUANA LEGALIZATION

WHAT WILL TRUMP 2.0 DO ABOUT LEGALIZING WEED? WE ASKED!



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media